Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized evaluator-blinded comparative study of Azzalure in women with glabellar frown lines
2013-004646-42Phase 4Completed
- Sponsor
- Q-Med
- Start
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of botulinum toxin type A in glabellar furrowing (2 arms), sponsored by Q-Med. Started Dec 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on 2013-004646-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004646-42.